Stem cells may be an attractive treatment for diabetic neuropathy. They have several advantages, including the ability to promote angiogenesis and restore normal nerve function. But there are a few issues that should be addressed before relying on this approach for diabetic neuropathy stem cell. These are discussed below. However, further studies are needed to determine whether this method is effective. This research is an alternative to cell transplantation therapy. It will be interesting to learn more about this treatment option.
Patients who have advanced neuropathy may benefit most from iPS cell therapy. This treatment uses a patient’s own blood to regenerate cells. It’s a low-risk procedure since the stem cells are derived from the patient’s own blood. The treatment is relatively simple: a patient receives an injection of a PRP solution into the affected area. This injection provides an additional boost to the body’s natural tissue regeneration process.
While research is in its early stages, stem cell therapy for diabetic neuropathy shows great promise. The treatment has many advantages over standard treatments, such as injections of blood. It may reduce total damage to peripheral nerves, improve tissue regeneration, and restore complete functional recovery. Although the procedure is not available for everyone, some patients have shown amazing results. Since nerve damage is systemic, treatment for this condition may differ from case to case.
Learn about stem cell therapy:
Although there is still much to learn about stem cell therapy for neuropathy, a small study found that it is effective. The treatment worked well in reducing pain in female patients suffering from neuropathy. Approximately 50% of the patients reported pain reduction after six months of treatment. They also used fewer anti-neuropathic medications. However, further studies are necessary. However, there are many scams out there – it is important to be cautious when purchasing stem cells.
A clinical trial conducted by Sino Stem Cells in 2011 on over thirty patients demonstrated positive results. After undergoing the procedure, 62.9% of patients reduced their insulin dosage by 50%. Three percent of Type 1 patients were able to discontinue insulin injections, and 11.1% of Type 2 patients stopped taking insulin altogether. It was reported that these results made the company expand their Diabetes Mellitus program in January 2011. The World Health Organization estimates that there are approximately 285 million people living with diabetes. And they expect this number to reach 438 million by 2030.
The researchers also found that diabetes-related mesenchymal stem cells have promising results in treating diabetic neuropathy. This cell treatment improves the expression of local neurotrophic factors, engrafts in the target tissue, and differentiates into tissue constituents. If successful, the treatment could potentially be used as a breakthrough for diabetic neuropathy. This research should help find a cure for the disease. There are currently no available therapies to cure diabetic neuropathy, so the main focus should be on preventing the condition and slowing its progression. The treatment of choice for diabetic neuropathy may include anti-seizure drugs and anti-depressants.
The best treatment option:
As diabetes-related nerve damage increases, stem cells may be the best treatment option. Mesenchymal stem cells release neuroprotective and neuroregenerative factors that help the body repair the damaged nerves. These cells can be found in the umbilical cord blood and compact bone. The Stem Cells Transplant Institute uses the stem cells derived from the umbilical cord. If the treatment is successful, mesenchymal stem cells will continue to provide benefits for the rest of the patient’s life.
Various conditions can cause diabetic neuropathy. High blood sugar and diabetes are two main causes of neuropathy. Certain types of chemotherapy have a toxic effect on healthy nervous tissue. A few viral conditions can cause damage to nerves. Car accidents and other types of trauma may also cause damage to the nerves, resulting in amputations of the foot or leg. Diabetes-related neuropathy can affect all aspects of life.
Moreover, stem cell therapies may improve the condition of peripheral nerves in diabetic patients. In diabetic patients, a small number of MSCs can be transplanted to the affected area. The transplanted cells are capable of differentiate into endothelial cells. Consequently, diabetes-related neuropathy can be treated with stem cells that have been isolated from the adipose tissue. Its potential is immense and the procedure is both safe and affordable.
